Chronic pain remains a significant challenge for modern health care as its pathologic mechanisms are largely unknown and preclinical animal models suffer from limitations in assessing this complex subjective experience. However, human brain neuroimaging techniques enable the assessment of functional and neurochemical alterations in patients experiencing chronic pain and how these factors may dynamically change with pharmacologic treatment
To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalg...
Abstract: Pregabalin is an antagonist of voltage gated Ca2+ channels and specifically binds to alpha...
Neuropathic pain is caused by a primary lesion or somatosensory system disorder. It is triggered by ...
Aim: To identify electroencephalographic (EEG) biomarkers for the analgesic effect of pregabalin in ...
Item does not contain fulltextAIM: To identify electroencephalographic (EEG) biomarkers for the anal...
BackgroundA lack of objective outcome measures and overreliance on subjective pain reports in early ...
BackgroundA lack of objective outcome measures and overreliance on subjective pain reports in early ...
Background: Lack of objective outcome measures and over-reliance on subjective pain reports in early...
BACKGROUND: Preclinical drug discovery for the treatment of chronic pain is at present challenged by...
Background Pregabalin has a broad spectrum of analgesic and antihyperalgesic activity in both basic ...
BACKGROUND: Preclinical drug discovery for the treatment of chronic pain is at present challenged by...
BACKGROUND A lack of objective outcome measures and overreliance on subjective pain reports in ea...
The fibromyalgia (FM) physiopathology involves an intracortical excitability/inhibition imbalance as...
BACKGROUND A lack of objective outcome measures and overreliance on subjective pain reports in ea...
To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalg...
To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalg...
Abstract: Pregabalin is an antagonist of voltage gated Ca2+ channels and specifically binds to alpha...
Neuropathic pain is caused by a primary lesion or somatosensory system disorder. It is triggered by ...
Aim: To identify electroencephalographic (EEG) biomarkers for the analgesic effect of pregabalin in ...
Item does not contain fulltextAIM: To identify electroencephalographic (EEG) biomarkers for the anal...
BackgroundA lack of objective outcome measures and overreliance on subjective pain reports in early ...
BackgroundA lack of objective outcome measures and overreliance on subjective pain reports in early ...
Background: Lack of objective outcome measures and over-reliance on subjective pain reports in early...
BACKGROUND: Preclinical drug discovery for the treatment of chronic pain is at present challenged by...
Background Pregabalin has a broad spectrum of analgesic and antihyperalgesic activity in both basic ...
BACKGROUND: Preclinical drug discovery for the treatment of chronic pain is at present challenged by...
BACKGROUND A lack of objective outcome measures and overreliance on subjective pain reports in ea...
The fibromyalgia (FM) physiopathology involves an intracortical excitability/inhibition imbalance as...
BACKGROUND A lack of objective outcome measures and overreliance on subjective pain reports in ea...
To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalg...
To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalg...
Abstract: Pregabalin is an antagonist of voltage gated Ca2+ channels and specifically binds to alpha...
Neuropathic pain is caused by a primary lesion or somatosensory system disorder. It is triggered by ...